α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Parkinson’s disease (PD) is characterized pathologically by intraneuronal inclusions called Lewy bodies, largely comprised of α-synuclein. Multiplication of the α-synuclein gene locus increases α-synuclein expression and causes PD. Thus, overexpression of wild-type α-synuclein is toxic. In this study, we demonstrate that α-synuclein overexpression impairs macroautophagy in mammalian cells and in transgenic mice. Our data show that α-synuclein compromises autophagy via Rab1a inhibition and Rab1a overexpression rescues the autophagy defect caused by α-synuclein. Inhibition of autophagy by α-synuclein overexpression or Rab1a knockdown causes mislocalization of the autophagy protein, Atg9, and decreases omegasome formation. Rab1a, α-synuclein, and Atg9 all regulate formation of the omegasome, which marks autophagosome precursors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





![Figure 6. α-Synuclein and Rab1a affect the colocalization of Atg9 and LC3 vesicles. (A) Endogenous immunostaining of Atg9 and p230 in SKNSH cells with α-synuclein overexpression or Rab1a knockdown. Empty GFP vector (EGFP) was used as a control for cells expressing α-synuclein–GFP. Images shown are z-stack projections. The Atg9 panels show a clear dispersal of the perinuclear localization with α-synuclein overexpression or Rab1a knockdown. Golgi fragmentation can be seen in the p230 columns. α-Synuclein overexpression causes an increase in the disorganization of the Golgi structure, a phenotype which is amplified with Rab1a knockdown. (Magnifications of these images have been deposited in the JCB DataViewer.) (B) Quantification of Atg9 colocalization with p230 (Pearson’s coefficient; ***, P < 0.001; two-tailed Student’s t test; n = 10 from one representative experiment). (C) Immunostaining of endogenous Atg9 and LC3 in cells with α-synuclein overexpression or Rab1a knockdown. Empty GFP vector (GFP) was used as a control for cells expressing α-synuclein–GFP. Colocalization is highlighted in white on merged panel (image generated by ImageJ Colocalization plugin). Images are single confocal planes to more precisely determine colocalization. Arrows denote colocalization events. (Magnifications of these images have been deposited in the JCB DataViewer.) (D and E) Quantification of Atg9 colocalization with LC3 (Pearson’s [D] and Mander’s coefficient [E]). The Mander’s coefficient shown in the first bar graph in E more accurately predicts Atg9/LC3 colocalization when LC3 vesicle number is reduced by Rab1a knockdown or α-synuclein overexpression (*, P < 0.05; **, P < 0.01; ***, P < 0.001; two-tailed Student’s t test; n = 10). (B, D, and E) Error bars represent SEM. See related Fig. S3. Bars: (A) 20 µm; (C) 10 µm.](https://figures.cochat.ai/paper-figures/72d18dd1e8114fddb91346cb34772324/synuclein-impairs-macroautophagy-implications-for-parkinsons-disease-figure-6.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pathologically meaningful levels of SNCA/α‐synuclein affect the intracellular localization of ATG9 via RAB1A (RAB1A, member RAS oncogene family), thereby perturbing autophagy dynamics in the brain of transgenic mice overexpressing SNCA/α‐synuclein (Winslow et al, 2010).”
From Autophagy in major human diseases (2021) · cites this paper as Winslow et al, 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Conversely, overexpression of wild-type synuclein impairs autophagic activity, implying a functional relationship between synuclein and autophagic degradation19.”
From Loss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice (2018) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605 · cited 2×
“Further lipidation of LC3-I creates the autophagosome-associated form, LC3-II, which is known to be a robust marker of autophagosomes (Kabeya et al., 2000).”
A guided tour into subcellular colocalization analysis in light microscopy
BOLTE, S., & CORDELIÈRES, F. P. (2006) · Journal of Microscopy · doi:10.1111/j.1365-2818.2006.01706.x · Cited by 5,324 · cited 1×
“Cells were imaged in z stacks, and images were analyzed by the JaCoP plugin (Bolte and Cordelières, 2006) in the ImageJ software.”
Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, K., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,203
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082 · cited 2×
“In addition to the accumulation of aggregate-prone proteins, the cells will not be as effective in clearing dysfunctional mitochondria (Twig et al., 2008) and will have increased susceptibility to certain apoptotic insults (Ravikumar et al., 2006); these are all processes that have been implicated…”
The role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865
Impairment of starvation-induced and constitutive autophagy in Atg7 -deficient mice
Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, N., Ohsumi, Y., Uchiyama, Y., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200412022 · Cited by 2,331 · cited 2×
“Mice defective for macroautophagy die soon after birth, and neuronal knockouts of such genes cause neurodegeneration accompanied by inclusion formation (Kuma et al., 2004; Komatsu et al., 2005).”
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
Klionsky, D. J., Abeliovich, H., Agostinis, P., Agrawal, D. K., Aliev, G., Askew, D. S., Baba, M., Baehrecke, E. H., Bahr, B. A., Ballabio, A., et al. (2008) · Autophagy · doi:10.4161/auto.5338 · Cited by 2,230 · cited 2×
“In this sense, the percentage of cells with mutant huntingtin aggregation can serve as a sensitive indicator of autophagic substrate clearance (Klionsky et al., 2008).”
Self-citationA Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118 · cited 1×
“62 (Jackson et al., 1998) with flies expressing wild-type -synuclein (UAS--syn; Feany and Bender, 2000) and with flies expressing constitutively active Rab1 (y1 P{UASp-YFP.”
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 8×
“Vol. 190 No. 6 1023–1037 www.jcb.org/cgi/doi/10.1083/jcb.201003122 JCB 1023 Correspondence to David C. Rubinsztein: dcr1000@hermes.cam.ac.uk Abbreviations used in this paper: ANOVA, analysis of variance; CMA, chaperonemediated autophagy; HD, Huntington’s disease; PD, Parkinson’s disease; PI(3)P, phosphatidylinositol-3…”
InfluentialAxe, E. L., Walker, S. A., Manifava, M., Chandra, P., Roderick, H. L., Habermann, A., Griffiths, G., & Ktistakis, N. T. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200803137 · Cited by 1,885 · cited 2×
“Thus, cells expressing GFP-labeled DFCP1 allow for the visualization of early events in autophagosome formation (Axe et al., 2008).”
Cited by
Items 301–400 of 826
Modulating lysosomal pH: a molecular and nanoscale materials design perspective
Zeng, J., Shirihai, O. S., & Grinstaff, M. W. (2020) · JoLS Journal of Life Sciences · doi:10.36069/jols/20201204 · Cited by 85
Progress of immunotherapy of anti-α-synuclein in Parkinson’s disease
Wang, Z., Gao, G., Duan, C., & Yang, H. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108843 · Cited by 60
Wang, X., Feng, S., Wang, Z., Yuan, Y., Chen, N., & Zhang, Y. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00914-2 · Cited by 69
Wilkaniec, A., Lenkiewicz, A. M., Babiec, L., Murawska, E., Jęśko, H. M., Cieślik, M., Culmsee, C., & Adamczyk, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.591475 · Cited by 63
“As overexpression of wt α-Syn was demonstrated to inhibit autophagosome formation, diminish LC3-II levels and induce accumulation of autophagy substrates (Winslow et al., 2010), the observed abnormalities in the elimination of damaged mitochondria may be associated with macroautophagy impairment.”
BackgroundArduíno, D. M., Esteves, A. R., & Cardoso, S. M. (2011) · Parkinson's Disease · doi:10.4061/2011/767230 · Cited by 59
Rohn, T. T., & Catlin, L. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020495 · Cited by 68
Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease
Wong, Y. C., & Krainc, D. (2016) · Movement Disorders · doi:10.1002/mds.26802 · Cited by 59
Yuan, Y., Wang, Y., Yuan, B., Yuan, X., Hou, X., Bian, J., Liu, C., & Hu, L. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.07.159 · Cited by 62
“Several pathogenic factors such as mitochondria dysfunction, neuroinflammation, circadian dysfunction, and autophagy impairment are considered to participate in PD pathogenesis (Li et al., 2017; Winslow et al., 2010).”
BackgroundRecent progress in the role of autophagy in neurological diseases
Meng, T., Lin, S., Zhuang, H., Huang, H., He, Z., Hu, Y., Gong, Q., & Feng, D. (2019) · Cell Stress · doi:10.15698/cst2019.05.186 · Cited by 58
“A30P and A53T mutations of α-synuclein can inhibit autophagy [123, 124], and up-regulation of transcription factor EB (TFEB), a key autophagy modulator [125], could alleviate lysosomal damage by promoting its biogenesis, thus relieving α-synuclein associated pathology of neurodegenerative diseases [126, 127].”
BackgroundClinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease
Benn, C., & Dawson, L. A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00242 · Cited by 61
Manzoni, C., & Lewis, P. A. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-49969-7_5 · Cited by 60
Glucocerebrosidase deficiency promotes release of α-synuclein fibrils from cultured neurons
Gegg, M. E., Verona, G., & Schapira, A. H. V. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa085 · Cited by 66
“Data are expressed as percentage of untreated (UT) neurons and are mean ± SEM (GBA protein, n =8; GBA mRNA, n =7). to reduce ER to Golgi trafficking (19, 33) and induce the unfolded protein response (UPR) (34–36).”
Deregulation of autophagy and vesicle trafficking in Parkinson’s disease
Sheehan, P., & Yue, Z. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.04.013 · Cited by 71
Kondo, K., Obitsu, S., & Teshima, R. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1078 · Cited by 57
Parkinson’s disease: From human genetics to clinical trials
van der Brug, M. P., Singleton, A., Gasser, T., & Lewis, P. A. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa8280 · Cited by 63
Neuroprotective effects of curcumin via autophagy induction in 6-hydroxydopamine Parkinson's models
He, H., Xiong, X., Zhou, S., Zhang, X., Zhao, X., Chen, L., & Xie, C. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105297 · Cited by 64
“Interestingly, α-syn overexpression inhibits autophagy at a very early stage of autophagosome formation, hence RNAi depletion of α-syn increases autophagy (Winslow et al., 2010).”
BackgroundWang, Z., Liu, J.-Y., Yang, C., Malampati, S., Huang, Y., Li, M., Li, M., & Song, J.-X. (2017) · Phytotherapy Research · doi:10.1002/ptr.5834 · Cited by 56
Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy
Ganguly, U., Chakrabarti, S. S., Kaur, U., Mukherjee, A., & Chakrabarti, S. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171129100944 · Cited by 61
“, and these processes would eventually result in further accumulation of αsynuclein [65-67].”
BackgroundInsulin and Autophagy in Neurodegeneration
de Mello, N. P., Orellana, A. M., Mazucanti, C. H., Lima, G. D. M., Scavone, C., & Kawamoto, E. M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00491 · Cited by 61
“Data from literature have been shown that overexpression of αSyn inhibits autophagy in cell culture and in vivo leading to accumulation of aggregateprone proteins (Winslow et al., 2010).”
BackgroundVesicle trafficking and lipid metabolism in synucleinopathy
Fanning, S., Selkoe, D. J., & Dettmer, U. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02177-z · Cited by 60
Cognitive heterogeneity in Parkinson’s disease: A mechanistic view
Carceles‐Cordon, M., Weintraub, D., & Chen‐Plotkin, A. S. (2023) · Neuron · doi:10.1016/j.neuron.2023.03.021 · Cited by 66
Sharma, J., di Ronza, A., Lotfi, P., & Sardiello, M. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-080317-061804 · Cited by 55
Selective Autophagy by Close Encounters of the Ubiquitin Kind
Vainshtein, A., & Grumati, P. (2020) · Cells · doi:10.3390/cells9112349 · Cited by 63
“The usual aggregate prone suspects, including amyloid-β [82], huntingtin [83,84], and alpha synuclein [85], can all be degraded through this process.”
BackgroundOh, S., & Roh, C. (2017) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2017.60.3.241 · Cited by 61
“Similarly, Parkinson’s disease is characterized by the accumulation of α-synuclein aggregate in Lewy bodies—neural cytoplasmic inclusions that impair autophagic clearance [64].”
Backgroundα-Synuclein levels modulate Huntington's disease in mice
Corrochano, S., Renna, M., Carter, S., Chrobot, N., Kent, R., Stewart, M. E., Cooper, J. D., Brown, S. D. M., Rubinsztein, D. C., & Acevedo‐Arozena, A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr477 · Cited by 59
Self-citationModulation of Autophagy by Calcium Signalosome in Human Disease
Filippi‐Chiela, E. C., Viegas, M. S., Thomé, M. P. M., Buffon, A., Wink, M. R., & Lenz, G. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.105171 · Cited by 58
Lipids and Lipid-Binding Proteins in Selective Autophagy
de la Ballina, L. R., Munson, M. J., & Simonsen, A. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.05.051 · Cited by 57
Chiu, C.-C., Yeh, T.-H., Chen, R.-S., Chen, H.-C., Huang, Y.-Z., Weng, Y.-H., Cheng, Y.-C., Liu, Y.-C., Cheng, A.-J., Lu, Y.-C., et al. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00399 · Cited by 51
“Upregulated expression of α-Syn and phospho-α-Syn caused by miR-204-5p is expected to lead to the impairment of autophagic flux, which promotes ER stress (Winslow et al., 2010).”
BackgroundInfluentialWan, T., Weir, E. J., Johnson, M., Korolchuk, V. I., & Saretzki, G. C. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101953 · Cited by 52
“In addition, it was demonstrated previously that α -syn accumulation could have a negative impact on autophagy activity (Winslow et al., 2010).”
BackgroundGenetic causes of Parkinson's disease and their links to autophagy regulation
Pan, P., & Yue, Z. (2013) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(13)70037-3 · Cited by 58
Shamoto‐Nagai, M., Hisaka, S., Naoi, M., & Maruyama, W. (2018) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.18-25 · Cited by 57
Live cell imaging of signaling and metabolic activities
Depaoli, M. R., Bischof, H., Eroğlu, E., Burgstaller, S., Ramadani‐Muja, J., Rauter, T., Schinagl, M., Waldeck‐Weiermair, M., Hay, J., Graier, W. F., et al. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.06.003 · Cited by 54
Neurons and Glia Interplay in α-Synucleinopathies
Mavroeidi, P., & Xilouri, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094994 · Cited by 63
Yacoubian, T. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802810-0.00001-5 · Cited by 78
Nelson, M. P., Boutin, M., Tse, T. E., Lu, H., Haley, E., Ouyang, X., Zhang, J., Auray‐Blais, C., & Shacka, J. J. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.11.006 · Cited by 52
“Conversely, it has also been shown that excess α-syn inhibits the ALP (Mazzulli et al. 2011; Song et al. 2014; Winslow et al. 2010; Yap et al. 2013).”
Wilkaniec, A., Cieślik, M., Murawska, E., Babiec, L., Gąssowska-Dobrowolska, M., Pałasz, E., Jęśko, H. M., & Adamczyk, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113959 · Cited by 55
Hypoxia Signaling in Parkinson’s Disease: There Is Use in Asking “What HIF?”
Pinilla, L. L., Ugun‐Klusek, A., Rutella, S., & Girolamo, L. A. D. (2021) · Biology · doi:10.3390/biology10080723 · Cited by 60
“For example, autophagy impairment facilitates α-synuclein accumulation in the brain [82] and, in turn, α-synuclein aggregation can further hinder autophagy [83].”
BackgroundTomás‐Zapico, C., Diez-Zaera, M., Ferrer, I., Gómez‐Ramos, P., Morán, M. A., Miras‐Portugal, M. T., Díaz-Hernández, M., & Lucas, J. J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr507 · Cited by 55
CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
Pinjala, P., Tryphena, K. P., Prasad, R., Khatri, D. K., Sun, W., Singh, S. B., Gugulothu, D. B., Srivastava, S., & Vora, L. K. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00381-y · Cited by 66
“In genetic alterations, mutations of the SNCA gene [19], disruption of calcium homeostasis [20], impaired autophagy [21], oxidative stress, and other pathological conditions, the fibrillation process of α-syn starts with the formation of dimers from misfolded monomers, which further develop into small oligomeric subst…”
BackgroundIn Sickness and in Health: The Role of TRAPP and Associated Proteins in Disease
Brunet, S., & Sacher, M. G. (2014) · Traffic · doi:10.1111/tra.12183 · Cited by 52
Role of PGC-1α in Mitochondrial Quality Control in Neurodegenerative Diseases
Zhang, Q., Lei, Y.-H., Zhou, J.-P., Hou, Y.-Y., Wan, Z., Wang, H., & Meng, H. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02858-6 · Cited by 55
Pukaß, K., Goldbaum, O., & Richter‐Landsberg, C. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13256 · Cited by 49
“In contrast thereto, Winslow et al. (2010) reported the inhibition of macroautophagy after over-expression of wild-type a-syn in human neuroblastoma cells, whichwasmonitored by an increase in p62, and decreased levels of LC3-II and LC3-positive vesicles.”
Pantazopoulou, M., Brembati, V., Kanellidi, A., Bousset, L., Melki, R., & Stefanis, L. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15174 · Cited by 52
“Evidence supports the role of α-Syn aggregates in the inhibition of autophagy (Mazzulli, Zunke, Isacson, Studer, & Krainc, 2016; Volpicelli-Daley et al., 2014; Winslow et al., 2010).”
BackgroundRole of Autophagy Pathway in Parkinson’s Disease and Related Genetic Neurological Disorders
Themistokleous, C., Bagnoli, E., Parulekar, R., & Muqit, M. M. K. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168144 · Cited by 48
Mochizuki, Y., Ohashi, R., Kawamura, T., Iwanari, H., Kodama, T., Naito, M., & Hamakubo, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.395087 · Cited by 51
Spatial and Functional Aspects of ER-Golgi Rabs and Tethers
Saraste, J. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00028 · Cited by 52
Autophagy is inhibited by ubiquitin ligase activity in the nervous system
Crawley, O., Opperman, K. J., Desbois, M., Adrados, I., Borgen, M. A., Giles, A. C., Duckett, D. R., & Grill, B. J. (2019) · Nature Communications · doi:10.1038/s41467-019-12804-3 · Cited by 52
Autophagy‐associated non‐coding RNAs: Unraveling their impact on Parkinson's disease pathogenesis
Hussain, M. S., Moglad, E. H. O., Afzal, M., Sharma, S., Gupta, G., Sivaprasad, G. V., Deorari, M., Almalki, W. H., Kazmi, I. A., Alzarea, S. I., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14763 · Cited by 52
“67 Given the propagational features of hyperphosphorylated α - Syn, it has been proposed that its amount diminishes during autophagy.”
BackgroundThe unlikely partnership between LRRK 2 and α‐synuclein in Parkinson's disease
Cresto, N., Gardier, C., Gubinelli, F., Gaillard, M., Liot, G., West Andrew, B., & Brouillet, E. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14182 · Cited by 54
“Atg9 is implicated in the initiation of autophagosome formation (Winslow et al., 2010).”
Giovedì, S., Ravanelli, M. M., Parisi, B., Bettegazzi, B., & Guarnieri, F. C. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.602116 · Cited by 56
García-Huerta, P., Troncoso-Escudero, P., Jerez, C., Hetz, C., & Vidal, R. (2016) · Brain Research · doi:10.1016/j.brainres.2016.02.052 · Cited by 46
“Besides, LRRK2 mutations in PD have been linked to defects in lysosomal pH, calcium regulation, chaperone-mediated autophagy (Orenstein et al., 2013; Martinez-Vicente et al., 2008) and autophagy vesicular trafficking through interactions with RAB1 (Winslow et al., 2010).”
The neural chaperone proSAAS blocks α-synuclein fibrillation and neurotoxicity
Jarvela, T. S., Lam, H. A., Helwig, M., Lorenzen, N., Otzen, D. E., McLean, P. J., Maidment, N. T., & Lindberg, I. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601091113 · Cited by 46
“Overexpression and/or oligomerization of α-synuclein causes changes in membrane permeability (62), mitochondrial dysfunction (63), disruptions in endoplasmic reticulum/Golgi trafficking (64), lysosomal leakage (65), and impairment and inhibition of proteasomes (66, 67).”
BackgroundEmerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness
Cieri, D., Brini, M., & Calí, T. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.153 · Cited by 53
TRAPPC13 modulates autophagy and the response to Golgi stress
Ramírez‐Peinado, S., Ignashkova, T. I., van Raam, B. J., Baumann, J., Sennott, E. L., Gendarme, M., Lindemann, R. K., Starnbach, M. N., & Reiling, J. H. (2017) · Journal of Cell Science · doi:10.1242/jcs.199521 · Cited by 48
The autophagy-lysosomal pathway: General concepts and clinical implications
Kenney, D. L., & Benarroch, E. E. (2015) · Neurology · doi:10.1212/wnl.0000000000001860 · Cited by 45
Kim, H., Calatayud, C., Guha, S. K., Fernández‐Carasa, I., Berkowitz, L. A., Carballo‐Carbajal, I., Ezquerra, M., Fernández‐Santiago, R., Kapahi, P., Raya, Á., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0881-7 · Cited by 53
“Overexpression of α-SYN results in the inhibition of autophagy [77].”
BackgroundCalcium Signaling Deficits in Glia and Autophagic Pathways Contributing to Neurodegenerative Disease
Mustaly-Kalimi, S., Littlefield, A. M., & Stutzmann, G. E. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7266 · Cited by 45
Iron Dysregulation in Parkinson’s Disease: Focused on the Autophagy–Lysosome Pathway
Chen, L., Huang, Y., Cui, J., Song, N., & Xie, J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00390 · Cited by 50
Protein Quality Control Pathways at the Crossroad of Synucleinopathies
de Mattos, E. P., Wentink, A. S., Nussbaum-Krammer, C. I., Hansen, C., Bergink, S., Melki, R., & Kampinga, H. H. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-191790 · Cited by 47
Super-resolution imaging reveals α-synuclein seeded aggregation in SH-SY5Y cells
Sang, J. C., Hidari, E., Meisl, G., Ranasinghe, R. T., Spillantini, M. G., & Klenerman, D. (2021) · Communications Biology · doi:10.1038/s42003-021-02126-w · Cited by 56
Lysosomal positioning diseases: beyond substrate storage
Scerra, G., Pasquale, V. D., Scarcella, M., Caporaso, M. G., Pavone, L. M., & D'Agostino, M. (2022) · Open Biology · doi:10.1098/rsob.220155 · Cited by 52
Walker, L., & Attems, J. (2023) · Journal of Parkinson s Disease · doi:10.3233/jpd-230154 · Cited by 55
Calí, T., Ottolini, D., Vicario, M., Catoni, C., Vallese, F., Cieri, D., Barazzuol, L., & Brini, M. (2019) · Cells · doi:10.3390/cells8091072 · Cited by 50
Prionoid Proteins in the Pathogenesis of Neurodegenerative Diseases
Wells, C., Brennan, S. E., Keon, M., & Saksena, N. K. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00271 · Cited by 45
“Macroautophagic inhibition has been observed to contribute to cell death in aggregate-bearing cells, suggesting a possible role for loss-of-function processes in neurodegeneration (Winslow et al., 2010).”
Backgroundα-Synuclein, Lrrk2 and Their Interplay In Parkinson‘s Disease
Liu, G., Aliaga, L., & Cai, H. (2012) · Future Neurology · doi:10.2217/fnl.12.2 · Cited by 60
Martínez‐Vicente, M., & Vila, M. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.03.005 · Cited by 56
Comincini, S., Manai, F., Meazza, C., Pagani, S., Martinelli, C., Pasqua, N., Pelizzo, G., Biggiogera, M., & Bozzola, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020391 · Cited by 46
“Autophagy impairment is crucial in several diseases, in particular proteinopathies, such as Alzheimer’s [17], Parkinson’s [18] and Huntington’s [19].”
BackgroundMultitasking Rab Proteins in Autophagy and Membrane Trafficking: A Focus on Rab33b
Morgan, N. E., Cutrona, M. B., & Simpson, J. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163916 · Cited by 48
Ginkgolic acid promotes autophagy-dependent clearance of intracellular alpha-synuclein aggregates
Vijayakumaran, S., Nakamura, Y., Henley, J. M., & Pountney, D. L. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.103416 · Cited by 46
Alpha-Synuclein and the Endolysosomal System in Parkinson’s Disease: Guilty by Association
Teixeira, M., Sheta, R., Idi, W., & Oueslati, A. (2021) · Biomolecules · doi:10.3390/biom11091333 · Cited by 48
“It has been reported that, when monomeric forms of α-syn are overexpressed, macroautophagy is inhibited through the modulation of Rab1a activity, leading to the mislocalization of autophagy-related protein 9 (Atg9), a transmembrane protein normally expressed on autophagosomes [49].”
BackgroundPosttranslational Modifications and Clearing of α-Synuclein Aggregates in Yeast
Popova, B., Kleinknecht, A., & Braus, G. (2015) · Biomolecules · doi:10.3390/biom5020617 · Cited by 42
Endolysosomal dysfunction in Parkinson's disease: Recent developments and future challenges
Kett, L. R., & Dauer, W. T. (2016) · Movement Disorders · doi:10.1002/mds.26797 · Cited by 42
Singh, N., Haldar, S., Tripathi, A. K., McElwee, M. K., Horback, K., & Beserra, A. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5874 · Cited by 45
Protein misfolding and dysregulated protein homeostasis in autoinflammatory diseases and beyond
Agyemang, A. F., Harrison, S. R., Siegel, R. M., & McDermott, M. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0496-2 · Cited by 43
Crabtree, D., Dodson, M. B., Ouyang, X., Boyer‐Guittaut, M., Liang, Q., Ballestas, M. E., Fineberg, N. S., & Zhang, J. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12497 · Cited by 43
“Autophagy-lysosome dysfunction has been extensively reported in PD (Anglade et al. 1997; AlvarezErviti et al. 2010; Crews et al. 2010; Dehay et al. 2010; Geisler et al. 2010; Winslow et al. 2010).”
BackgroundMamais, A., Manzoni, C., Nazish, I., Arber, C., Sonustun, B., Wray, S., Warner, T. T., Cookson, M. R., Lewis, P. A., & Bandopadhyay, R. (2018) · Brain Research · doi:10.1016/j.brainres.2018.07.023 · Cited by 40
The small GTPase Rab32 resides on lysosomes to regulate mTORC1 signaling
Drizyte‐Miller, K., Chen, J., Cao, H., Schott, M. B., & McNiven, M. A. (2020) · Journal of Cell Science · doi:10.1242/jcs.236661 · Cited by 42
“For example, Rab1A has been proposed to activate both mTORC1 signaling in response to amino acid signaling at theGolgi as well as the formation of autophagosome vesicles (Huang et al., 2011; Thomas et al., 2014; Winslow et al., 2010).”
BackgroundNeuroprotective mechanism of Vernonia amygdalina in a rat model of neurodegenerative diseases
Oladele, J. O., Oyeleke, O. M., Oladele, O. T., & Olaniyan, M. D. (2020) · Toxicology Reports · doi:10.1016/j.toxrep.2020.09.005 · Cited by 48
Mechanisms of neuronal survival safeguarded by endocytosis and autophagy
Overhoff, M., Bruyckere, E. D., & Kononenko, N. L. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15194 · Cited by 46
“…several studies identified that α-Synuclein is degraded via autophagy, including the CMA (Vogiatzi et al., 2008; Webb et al., 2003), and that increased levels of α-Synuclein mediated by the gene duplication in PD can cause mislocalization of ATG9 and compromise autophagy (Winslow et al., 2010).”
BackgroundExploring the Role of Autophagy Dysfunction in Neurodegenerative Disorders
Rana, T., Behl, T., Sehgal, A., Mehta, V., Singh, S., Bhatia, S., Al‐Harrasi, A., & BUNGAU, S. G. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02472-0 · Cited by 42
Nanomedicine in the Face of Parkinson’s Disease: From Drug Delivery Systems to Nanozymes
Padilla-Godínez, F. J., Ruiz-Ortega, L. I., & Guerra‐Crespo, M. (2022) · Cells · doi:10.3390/cells11213445 · Cited by 42
“Furthermore, α-syn also inhibits the expression of proteins necessary for the assembly of autophagosomes, impairing macroautophagy [59].”
BackgroundUnfolded Protein Response and Macroautophagy in Alzheimer’s, Parkinson’s and Prion Diseases
Milisav, I., Šuput, D., & Ribarič, S. (2015) · Molecules · doi:10.3390/molecules201219865 · Cited by 43
Yan, D., Liu, C., Tan, X., Ma, Z., Wang, C., Deng, Y. L., Liu, W., Xu, Z., & Xu, B. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00016-y · Cited by 39
The role of lipids in autophagy and its implication in neurodegeneration
Hernández-Díaz, S., & Soukup, S. (2020) · Cell Stress · doi:10.15698/cst2020.07.225 · Cited by 42
Endosomal-lysosomal dysfunction in metabolic diseases and Alzheimer's disease
(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.02.012 · Cited by 38
“It is notable that α-synuclein is a regulator of the autophagic network (Winslow et al., 2010) in addition to being a substrate of the autophagy-lysosomal pathway (Hwang et al.”
BackgroundSelectivity of Lewy body protein interactions along the aggregation pathway of α-synuclein
Leitao, A. D. G., Rudolffi-Soto, P., Chappard, A., Bhumkar, A., Lau, D., Hunter, D. J. B., Gambin, Y., & Sierecki, E. (2021) · Communications Biology · doi:10.1038/s42003-021-02624-x · Cited by 42
Fox, S. N., McMeekin, L. J., Savage, C. H., Joyce, K. L., Boas, S. M., Simmons, M. S., Farmer, C. B., Ryan, J., Pereboeva, L., Becker, K., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00369-w · Cited by 41
The neurotoxicity of pesticides: Implications for Parkinson's disease
Amaral, L., Martins, M., Côrte‐Real, M., Outeiro, T. F., Chaves, S. R., & Rego, A. (2025) · Chemosphere · doi:10.1016/j.chemosphere.2025.144348 · Cited by 51
“…processes, including inhibition of Ras-related protein (RAB1A), mislocalization of autophagy-related protein 9 (ATG9), and reduced formation of autophagic structures associated with the ER (Winslow et al., 2010), and disruption of the autophagolysosome maturation process (Sarkar et al., 2021).”
Hung, K.-C., Huang, H.-J., Lin, M., Lei, Y.-P., & Lin, A. M.-Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091074 · Cited by 40
Bogéa, T. H., Wen, R. H., & Moritz, O. L. (2015) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.15-16799 · Cited by 38
Vijayan, B., Raj, V., Nandakumar, S., Kishore, A., & Thekkuveettil, A. (2018) · Cell Biology and Toxicology · doi:10.1007/s10565-018-09449-1 · Cited by 38
Adams, J., Feuerborn, M., Molina, J. A., Wilden, A. R., Adhikari, B., Budden, T., & Lee, S. Y. (2019) · Scientific Reports · doi:10.1038/s41598-018-36379-z · Cited by 38
In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategies
Marvian, A. T., Koss, D. J., Aliakbari, F., Morshedi, D., & Outeiro, T. F. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14707 · Cited by 39
Miki, Y., Tanji, K., Mori, F., Tatara, Y., Utsumi, J., Sasaki, H., Kakita, A., Takahashi, H., Fimia, G. M., & Wakabayashi, K. (2017) · Brain Pathology · doi:10.1111/bpa.12461 · Cited by 41
“An overload of abnormal a-syn is known to halt autophagy (43, 50).”
BackgroundPupyshev, A. B., Короленко, Т. А., Akopyan, A. A., Amstislavskaya, T. G., & Tikhonova, M. A. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.12.001 · Cited by 45
Seidenberg, J., Stellato, M., Hukara, A., Ludewig, B., Klingel, K., Distler, O., Błyszczuk, P., & Kania, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041861 · Cited by 37
Sastre, A. A., Montoro, M. L., Lacerda, H. M., Llavero, F., & Zugaza, J. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094425 · Cited by 41
Jiang, P., Gan, M., Lin, W.-L., & Yen, S.-H. C. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00268 · Cited by 43
α-Synuclein and nonhuman primate models of Parkinson's disease
Vermilyea, S., & Emborg, M. E. (2015) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2015.07.025 · Cited by 44
“Overexpression of α-syn in vitro has been shown to disrupt or inhibit the autophagy pathway (Winslow et al., 2010).”
BackgroundDiversity in the Regulation of Autophagy and Mitophagy: Lessons from Parkinson's Disease
Chu, C. T. (2011) · Parkinson's Disease · doi:10.4061/2011/789431 · Cited by 36
“While upregulation of macroautophagy can mediate clearance of αsynuclein aggregates in metabolically intact cells [43], reports that α-synuclein can affect mitochondrial metabolism [44] and macroautophagy efficiency [45] raise additional questions.”
Background
Metadata
- Authors
- Winslow, A. R., Chen, C.-W., Corrochano, S., Acevedo-Arozena, A., Gordon, D. E., Peden, A. A., Lichtenberg, M., Menzies, F. M., Ravikumar, B., Imarisio, S., Brown, S., O’Kane, C. J., & Rubinsztein, D. C.
- Affiliations
- University of Cambridge (GB)
- Medical Research Council (GB)
- Mammalian Genetics Unit, Medical Research Council Harwell, Oxfordshire OX11 0RD, England, UK 4
- Corresponding author
- Rubinsztein, David C.
- ORCID
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2010-09-20
- Volume
- 190
- Issue
- 6
- Pages
- 1023-1037
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3101586
- OpenAlex
- W2142047537
- Cited by
- 825
- References
- 51
- Citations by year
- 2026: 36 · 2025: 41 · 2024: 55 · 2023: 45 · 2022: 42 · 2021: 51 · 2020: 66 · 2019: 72 · 2018: 57 · 2017: 66 · 2016: 65 · 2015: 53 · 2014: 37 · 2013: 43 · 2012: 51
- FWCI
- 26.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Funders
- Wellcome Trust (FP7/2007–2013, 089703)
- European Commission (241791)
- Cambridge Trust
- Medical Research Council (MC_G1000734)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- alpha-synuclein, macroautophagy, Parkinson's disease, Rab1A, Atg9, Lewy bodies, transgenic mice
- MeSH terms
- Animals, Autophagy, Drosophila melanogaster, Golgi Apparatus, Humans, Membrane Proteins, Microtubule-Associated Proteins, Models, Biological, Parkinson Disease, Phagosomes, rab1 GTP-Binding Proteins, Protein Transport, Secretory Vesicles, Cell Line, Tumor, Mice, alpha-Synuclein, Gene Knockdown Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.